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ABSTRACT 
Background: Bacterial endophthalmitis a serious complication of ocular 
surgery and penetrating trauma. The primary causative organisms are strains 
of Staphylococcus aureus and Staphylococcus epidermidis. Fluoroquinolones are 
widely used to treat endophthalmitis. There are a few studies on the penetra- 
tion of fluoroquinolones into the lens in inflamed eyes. A literature search did 
not identify any data regarding penetration of topical ofloxacin into the lens in 
normal and inflamed eyes. 
Objective: The aim of this study was to determine the penetration of topical 
ofloxacin and lomefloxacin into the lens in a rabbit endophthalmitis model. 
Methods: New Zealand white rabbits were randomly divided into 2 groups. 
The left eyes were infected with an intravitreal inoculation of S aureus. The right 
eyes were used as a noninoculated control. Groups 1 and 2 received topical 
ofloxacin and lomefloxacin treatment, respectively, 24 hours after the inocula- 
tion. Two drops of the study drugs were instilled in the eyes every 30 minutes 
for 3 hours and then every 60 minutes for 3 hours. Lens samples were obtained 
30 minutes after the last ofloxacin or lomefloxacin drops were administered. 
High-performance liquid chromatography was used to determine the fluoro- 
quinolone concentration. 
Results: Ten rabbits were equally divided into the 2 treatment groups. There 
was no significant difference in mean (SD) lens concentrations between the con- 
trol and inoculated eyes in either treatment group--ofloxacin (0.26 [0.32] pg/mL 
vs 0.11 [0.05] pg/mL, respectively) and lomefloxacin (0.50 [0.87] pg/mL vs 
0.12 [0.08] pg/mL, respectively). 
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Conclusions: The results of this small experimental study found that topical 
ofloxacin and lomefloxacin can accumulate in the crystalline lens after installa- 
tion. Inflammation did not affect the penetration of ofloxacin or lomefloxacin 
into the lens. (Curr Ther Res Ciin Exp. 2007;68:184-190) Copyright © 2007 
Excerpta Medica, Inc. 
Key words: experimental endophthalmitis, fluoroquinolone, ofloxacin, lome- 
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INTRODUCTION 
The first quinolone, nalidixic acid, was introduced in 1962.1 Since then, struc- 
tural modifications have been made and quinolones have improved gram-positive 
coverage. Quinolones block bacterial DNA synthesis by inhibiting topoiso- 
merase nzymes. Quinolones are bactericidal and are active against avariety of 
gram-negative and gram-positive bacteria. 2,3 
Although there have been several studies 4-1° of the penetration of topical fluo- 
roquinolones into the aqueous and vitreous humor, reports on penetration 
of these antimicrobials into the lens are limited. 11,12 Furthermore, a literature 
search (MEDLINE, years 1980-2006, English language; key terms: fluoroquinolone, 
ofloxacin, lomefloxacin, and lens penetration) did not identify any data on lens 
penetration of topically administered ofloxacin in normal and inflamed eyes. It is 
important to determine the amount of drug that penetrates into the lens because 
the lens may act as a reservoir of active agents, meaning that excessive use may 
result in accumulation of the drug and may cause opacities. 
The aim of this study was to determine and compare the concentrations of
ofloxacin and lomefloxacin in the lens after topical instillation in normal and 
inflamed eyes. 
METHODS 
New Zealand white rabbits weighing between 2.1 and 3.0 kg were equally 
divided into 2 groups (groups 1 and 2). The animals were treated according to 
the Association for Research in Vision and Ophthalmology Statement for the 
Use of Animals in Ophthalmic and Vision Research. 13 Each animal was housed 
in a separate cage and was given food and water ad libitum. The study protocol 
was reviewed and approved by the Ankara Training and Research Hospital ethics 
committee, Ankara, Turkey. 
Endophthalmitis Model 
All rabbits were anesthetized using an IM injection of xylazine hydrochloride 
10 mg/kg and ketamine hydrochloride 50 mg/kg. All intravitreal injections were 
made-2  mm from the superonasal limbus with a 27-gauge needle attached to a 
1-mL tuberculin syringe (TIBSET A.S., Istanbul, Turkey). The left eye of each ani- 
mal was used for study drug injections, whereas the right eye was used as a 
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noninoculated control. Staphylococcus aureus (ATCC ® 29213, American Type 
Culture Collection, Manassas, Virginia) was used to induce intraocular infection. 
Fluoroquinolone Treatment 
Twenty-four hours after bacterial inoculation, 2drops of commercially avail- 
able ofloxacin 0.3% (Exocin ®, Allergan, Westport, Ireland) and lomefloxacin 0.3% 
(Okacin ®, Novartis Pharma AG, Basel, Switzerland) were instilled into the eyes 
of the animals in group 1 and 2, respectively, every 30 minutes for 3 hours and 
then every 60 minutes for 3 hours. Thirty minutes after the last fluoroquinolone 
administration, lenses were extracted and samples were stored at -80°C until 
analysis. 
The investigators who instilled the drops were not masked to the study 
group, while the investigators who analyzed the lens samples were masked. 
High-Performance Liquid Chromatography of Fluoroquinolone 
Concentrations 
Concentrations of ofloxacin and lomefloxacin in the lens samples were mea- 
sured using high-performance liquid chromatography, as described previous- 
ly. 14,1s The separation was performed on a Radial-pak, C18 cartridge column 
(100 × 8 mm i.d., particle size 10 mm) and precolumn (C18) (Waters Corp., 
Milford, Massachusetts). The sample elution was monitored on a fluorescence 
detector using excitation and emission wavelengths of 280 and 455 nm, respec- 
tively. The mobile phase consisted of acetonitrile and 0.1 M of sodium dihydro- 
gen phosphate (2:8 [v/v]; pH = 3.9). The mobile phase was delivered at a flow 
rate of 2 mL/min. Quinine sulfate was used as an internal standard (2 mg/mL). 
Lens samples were homogenated and centrifuged at 8000 rpm for 5 minutes. 
The supernatant was directly injected after dilution and addition of quinine sul- 
fate; 20 pL of aliquot were injected through the column. The within-day and day- 
to-day precision values were <9% for the 2 drugs at 0.05, 0.1, and 0.4 mg/mL (n = 
6); the within-day and day-to-day accuracy values were in the range of 96.3% to 
102.7% for the drugs at the concentrations given; the detection limit correspond- 
ing to a signal-to-noise ratio of 3:1 was 0.6 ng/mL. 14,15 
Statistical Analysis 
Data were expressed as mean (SD) and range. Concentrations of fluoroquino- 
lones in normal and infected lenses were compared using the Kruskal-Wallis test, 
a nonparametric test for paired samples. P < 0.05 was considered statistically 
significant. All statistical analyses were carried out using Statistical Packages for 
Social Sciences (SPSS) software version 10.0 (SPSS Inc., Chicago, Illinois). 
RESULTS 
The mean (SD) lens concentrations of the control and inoculated eyes for 
ofloxacin (0.26 [0.32] pg/mL and 0.11 [0.05] pg/mL, respectively) and lome- 
floxacin (0.50 [0.87] pg/mL and 0.12 [0.08] pg/mL, respectively) are shown in 
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Tables I and I1, respectively. There were no significant differences between 
the 2 groups. 
DISCUSSION 
Based on a search of the literature, this is the first study reporting topical 
ofloxacin drug concentrations in the crystalline lens. In this study, inflammation 
did not affect lens penetration of topically applied ofloxacin and lomefloxacin. 
These results suggest the need for more studies of ofloxacin in the treatment of 
ocular lens infectious diseases, particularly in lenticular abscesses. 
Superficial and deep ocular infections, such as conjunctivitis, corneal ulcers, 
and endophthalmitis, are caused by a diverse group of bacterial, viral, and fungal 
pathogens. Bacterial endophthalmitis most commonly occurs as a postoperative 
complication, but it may also result from penetrating ocular trauma or systemic 
Table I. Lens concentrations of ofloxacin in the normal (control) and 
Staphylococcus aureus-inoculated eyes of New Zealand white 
rabbits (n = 5). 
Topical Ofloxacin Concentration, lag/mL 
Rabbit Control Eye Inoculated Eye 
1 0.07 0.12 
2 0.08 0.06 
3 0.13 0.18 
4 0.19 0.13 
5 0.83 0.06 
Mean (SD)* 0.26 (0.32) 0.11 (0.05) 
*No statistically significant difference was observed. 
Table II. Lens concentrations of Iomefloxacin in the normal (control) 
and Staphylococcus aureus-inoculated eyes of New Zealand 
white rabbits (n = S). 
Topical Lomefloxacin Concentration, IJg/mL 
Rabbit Control Eye Inoculated Eye 
1 2.05 0.23 
2 0.12 0.08 
3 0.05 0.16 
4 0.06 0.07 
5 0.22 0.04 
Mean (SD)* 0.50 (0.87) 0.12 (0.08) 
*No statistically significant difference was observed. 
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infection. 16'17 Despite the best available treatment, he treatment success in the 
patients with endophthalmitis is still insufficient. Staphylococcus epidermidis and 
S aureus are primary causes of postoperative bacterial endophthalmitis, la Topical 
fluoroquinolones are used in the treatment of ocular infectious diseases. 19 
The penetration of topical fluoroquinolones into several ocular tissues has 
been well documented. 5,7,11,2° Topical ofloxacin has been reported in clinical stud- 
ies to penetrate ocular structures significantly better than the other first- and second- 
generation fluoroquinolones. 21,22 In the present study, we found the mean lens 
drug concentration to be 0.26 pg/mL (range, 0.07-0.83 pg/mL) for ofloxacin and 
0.50 pg/mL (range, 0.05-2.05 pg/mL) for lomefloxacin in control eyes. 
Aqueous and vitreous humor penetration of ofloxacin has been shown to 
increase in the inflamed eye. 23,24 In the current study, topical ofloxacin and 
lomefloxacin yielded a mean concentration of 0.11 pg/mL (range, 0.06- 
0.18 pg/mL) and 0.12 pg/ml (range, 0.04-0.23 pg/mL) in the lens of inoculated 
eyes, respectively. Inflammation did not significantly affect lens concentrations 
of either ofloxacin or lomefloxacin compared with the control eyes. In addition, 
these concentrations were lower than the MIC of S aureus, which is 0.63 pg/mL 
for ofloxacin 25 and 0.78 pg/mL for lomefloxacin. 26Although the dosing regi- 
men we used in this study did not reach a sufficient concentration to cover 
the infecting pathogens, different dosing regimens and different application 
methods (ie, oral plus topical) might allow the drugs to reach therapeutic 
concentrations. 
This study supports the lenticular presence of topical ofloxacin and lome- 
floxacin. The small number of rabbits used was a limitation for the comparison 
of the drug concentrations between normal and inflamed eyes. For example, 
assuming a power of 90% and an cz of 0.05,-20 rabbits per group would be 
needed to show a significant difference. Another limitation of the study was the 
instillation method, which did not allow precise control of the amount of antibi- 
otic instilled. 
CONCLUSIONS 
These results indicate that topical ofloxacin and lomefloxacin can accumulate 
in the lens and inflammation does not influence lens penetration of these 2 fluo- 
roquinolones. Further studies are needed to demonstrate the effect of treat- 
ment protocol on the concentrations of topical fluoroquinolones in the lens and 
to investigate the effect of fluoroquinolone accumulation i the human lens. 
REFERENCES 
1. Oliphant CM, Green GM. Quinolones: A comprehensive r view. Am Fam Physician. 
2002;65:455-464. 
2. Blondeau JM. Fluoroquinolones: Mechanism of action, classification, and develop- 
ment of resistance. Surv Ophthalmol. 2004;49(Suppl 2):$73-$78. 
3. Hooper DC, Wolfson JS. Fluoroquinolone antimicrobial gents. N Engl J Med. 1991; 
324:384-394. 
188 
R. Ya~ci et aL 
4. Velpandian T, Gupta SK, Gupta YK, et al. Comparative studies on topical omefloxacin 
and ciprofloxacin on ocular kinetic and experimental corneal ulcer. J Ocul Pharmacol 
Ther. 1999;15:505-511. 
5. Ozturk E Kurt E, Inan UU, et al. Penetration of topical and oral ofloxacin into the 
aqueous and vitreous humor of inflamed rabbit eyes. Int J Pharm. 2000;204:91-95. 
6. Cekic O, Batman C, Yasar U, et al. Comparison of aqueous humour and vitreous 
humour levels of two 0.3% ciprofloxacin eyedrops. Can J Ophthalmol. 1998;33:373- 
376. 
7. Donnenfeld ED, Perry HD, Snyder RW, et al. Intracorneal, aqueous humor, and vitre- 
ous humor penetration of topical and oral ofloxacin. Arch Ophthalmol. 1997;115: 
173-176. 
8. Yalvac IS, Basci NE, Bozkurt A, Duman S. Penetration of topically applied cipro- 
floxacin and ofloxacin into the aqueous humor and vitreous. J Cataract Refract Surg. 
2003;29:487-491. 
9. Cekic O, Batman C, Totan Y, et al. Aqueous humour levels of topically applied 
ciprofloxacin and ofloxacin in the same subjects. Eye. 1999;13:656-659. 
10. Yamada M, Mochizuki H, Yamada K, et al. Aqueous humor levels of topically applied 
levofloxacin, norfloxacin, and lomefloxacin in the same human eyes. J Cataract 
Refract Surg. 2003;29:1771-1775. 
11. Elena PP, Jauch A. Ocular distribution of lomefloxacin 0.3% after a single instillation 
in the infected eye of pigmented rabbits. J Ocul Pharmacol Ther. 1997;13:551-558. 
12. Fisch A, Lafaix C, Salvanet A, et al. Ofloxacin in human aqueous humour and lens. 
J Antimicrob Chemother. 1987;20:453-454. 
13. The Association for Research in Vision and Ophthalmology. Statement for the use of 
animals in ophthalmic and visual research [ARVO Web site]. Available at: 
http://www.ar vo. org/eweb/dynamicpage, spx?site=ar vo2&webcode=AnimalsReser ch. 
Accessed May 25, 2004. 
14. Jim LK, el-Sayed N, al-Khamis KI. A simple high-performance liquid chromatographic 
assay for ciprofloxacin in human serum. J Clin Pharm Ther. 1992;17:111-115. 
15. Basci NE, Bozkurt A, Kalayci D, Kayaalp SO. Rapid liquid chromatographic assay of 
ciprofloxacin in human aqueous humor. J Pharm Biomed Anal. 1996;14:353-356. 
16. Puliafito CA, Baker AS, Haaf J, Foster CS. Infectious endophthalmitis. Review of 
36 cases. Ophthalmology. 1982;89:921-929. 
17. Shrader SK, Band JD, Lauter CB, Murphy E The clinical spectrum of endophthalmi- 
tis: Incidence, predisposing factors, and features influencing outcome. J Infect Dis. 
1990;162:115-120. 
18. Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrec- 
tomy Study. A randomized trial of immediate vitrectomy and of intravenous anti- 
biotics for the treatment of postoperative bacterial endophthalmitis. Arch 
Ophthamol. 1995; 113:1479-1496. 
19. Leeming JE Treatment of ocular infections with topical antibacterials. Clin Pharma- 
cokinet. 1999;37:351-360. 
20. Mizuki N, Watanabe Y, Miyamoto M, et al. Flomoxef sodium and levofloxacin concen- 
trations in aqueous humor. Ocul Immunol lnflamm. 2005; 13:229-234. 
21. Diamond JP, White L, Leeming JE et al. Topical 0.3% ciprofloxacin, norfloxacin, and 
ofloxacin in treatment of bacterial keratitis: A new method for comparative evalua- 
tion of ocular drug penetration. Br J Ophthalmol. 1995;79:606-609. 
189 
CURRENT THERAPEUTIC RESEARCH 
22. Cekic O, Batman C, Totan Y, et al. Penetration of ofloxacin and ciprofloxacin in aque- 
ous humor after topical administration. Ophthalmic Surg Lasers. 1999;30:465--468. 
23. Behrens-Baumann W. Absorption of topically administered ciprofloxacin, ofloxacin 
and gentamicin i  the inflamed rabbit eye. Ophthalmologica. 1996;210:119-122. 
24. Gatti G, Panozzo G. Effect of infammation on intraocular penetration of intravenous 
ofloxacin in albino rabbits. Antimicrob Agents Chemother. 1995;39:549-552. 
25. Mather R, Karenchak LM, Romanowski EG, Kowalksi RP. Fourth generation fluoro- 
quinolones: New weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol. 
2002;133:463-466. 
26. Yamada M, Ishikawa K, Mochizuki H, Kawai M. Corneal penetration ofsimultaneously 
applied topical levofloxacin, norfloxacin and lomefloxacin in human eyes. Acta 
Ophthalmol Scand. 2006;84:192-196. 
Address correspondence to: Ramazan Y~gc~, MD, Fakiilteler M. Keskin S. 9/3 
Cebeci, 06590 ~ankaya/Ankara, Turkey. E-mail: ramazanyagc i~ahoo.com 
190 
